chrisvoncsefalvay/vaers-outcomes huggingface dataset:
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   The reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported for the nurse the reporter used to know. The age at vaccination was not reported. The patient got shingles from the Shingles vaccine. She was miserable for a few weeks. The reporter specified that this did not encourage the reporter to get the shot. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Facial swelling, heart rate increase, chills, a little dizziness.  Immediately went back to doctors office and they monitored my heart rate and blood pressure for next 2 hours.
Issues: vertigo, dizziness, headaches, migraine-like sensations, gastric distress Treatment (started on 4/5/21; planned to be for 1 month): energy work, herbal supplements, homeopathic supplements
ry of Present Illness  The patient presents with worsening of chronic dyspnea over past 4 days which was said to have been ongoing for years. Has had to increase O2 from 2L baseline. Also reports some swelling of the LE BL and cough. Denies use of anticoagulants, denies fever, denies nausea, denies Hx DVT. Pt has a h/o lung cancer not currently on chemo.  The onset was chronic.  The course/duration of symptoms is worsening (over past 4 days).  Risk factors consist of hypertension and Lung cancer.  Therapy today: oxygen and emergency medical services.
Pt was given a DTaP rather than a Tdap. He had no adverse reactions.
Reported shortness of breath one day post vaccination with AVA # 2. Noted that his arm felt tight with tingling for one week and that his nodes felt tender. Noticed occasional headaches AVA # 4, increase in headaches after # 5. He would get 2-3 headaches per week, associated with nausea, and would last approx. 24 hrs. Headaches eventually cleared but returned after deployment. Also reported that approx 1 wk after #5, he wife said he stopped breathing while he was sleeping and she had to pound on him to wake him up. Symptom: Headache(784.0).
That morning his leg had a splotchy rash, but by that afternoon the rash had spread considerably and his leg had doubled in size.
Having a Gout flare-up. Went to the doctor in regard to the Gout flare-up. Was given the Shingrix vaccine. It is reported on the CDC website that if a patient is in the midst of a chronic illness that the Shingrix vaccine should  not be administered. Shingrix vaccine was administered anyway. Patient is now dealing with pain extending from his wrist up to his shoulder.
Next day post vax, the pt started running a fever of 101, had been given Tylenol already. By later afternoon, temperature was 105. Mother states she called physician's office and they paged him. She states physician did not want to see child. Mother to child to ER and they gave him a shot, she wasn't sure what. After she got back home, child began to have seizures and she has not had any seizures since.
Severe headache that did not respond to over the counter medications lasted about 36 hours. After that it continued but not nearly as severe and did respond to over the counter medications. Headache still present
Day after vaccine administered experienced pain at site of injection, low grade fever and body aches.  One day after noticed redness, warmth and induration at injection site.  Pt states she noticed bruising by day two and pain still noticable.  At day five employee shows up to clinic, slight discoloration noted to skin, no warmth
Wanted to sleep all day long; injection site arm site temperature is hot; injection site arm mild itching; injection site arm swelling; injection site arm redness; injection site arm under the arm painful; developed a headache; injection site arm swollen lymph node; Felt tired all day, just tired; Sore arm; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Wanted to sleep all day long), INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), MYALGIA (Sore arm) and HEADACHE (headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included KETOROLAC TROMETHAMINE (TORADOL) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced MYALGIA (Sore arm), HEADACHE (headache) and CHILLS (chills). On 10-Feb-2021, the patient experienced FATIGUE (Felt tired all day, just tired). On 17-Feb-2021, the patient experienced INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), INJECTION SITE SWELLING (injection site arm swelling), INJECTION SITE ERYTHEMA (injection site arm redness), VACCINATION SITE PAIN (injection site arm under the arm painful), HEADACHE (developed a headache) and VACCINATION SITE LYMPHADENOPATHY (injection site arm swollen lymph node). On an unknown date, the patient experienced SOMNOLENCE (Wanted to sleep all day long). At the time of the report, SOMNOLENCE (Wanted to sleep all day long) and CHILLS (chills) had resolved and INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), MYALGIA (Sore arm), HEADACHE (headache), FATIGUE (Felt tired all day, just tired), INJECTION SITE SWELLING (injection site arm swelling), INJECTION SITE ERYTHEMA (injection site arm redness), VACCINATION SITE PAIN (injection site arm under the arm painful), HEADACHE (developed a headache) and VACCINATION SITE LYMPHADENOPATHY (injection site arm swollen lymph node) outcome was unknown.            No treatment information was provided. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-013647 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Follow up information and had significant information.  Reporter information, patient demographics, dosage information, new events  Somnolence and fatigue were updated.
Sore throat, swollen glands, red throat & adenopathy; this is not a vax rxn;
Fainted. Given pt juice and waited 10-15 mins and pt feel better and head to home.
At the evening first veins started to bulge ( on the left arm), than they moved to the Lt neck, Lt and Rt breast and by the morning i had it on Bilateral popliteal fossas ( behind both knees). I called to Moderna and they said they do not know what to do with it. It looks like vein blockage and thrombosis
Low grade fever, chills, headache, nausea, body aches, lack of energy, lack of appetite
pt seen in ER p/ c/o chest pains onset 1 hr p/vax;
Severe diarrhea, vomiting, migraine headache, chills and fever for two days
About 4 hours after getting the vaccine that day I felt severe pain in my arm, chills, headache and fever. The next day I had more pain in my arm and at night I had an episode of diarrhea, nasal congestion for a week, and over the months the pain has intensified and is more frequent. I got COVID on January 20, 2022 and the headaches were bad. Now in my left arm I feel like ants and it feels weak.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Dizziness / Lightheadness-Mild
pt had a high, pitch & unusual cry which was reported to us by the parents & which occurred on 10MAR94 (early AM);
Low fever, headache, muscle aches, lethargy, nausea, arm soreness
Fatigue; Nausea; Joint pain; Light headache; Brain fog; Trouble concentrating; High anxiety; Loss of taste; This is a spontaneous report from a contactable consumer (patient). A 26-years-old non-pregnant female patient received (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution For Injection, Lot Number: ER2013) via an unspecified route of administration, administered in Arm Left on 21Mar2021 (at the age of 26 years) dose 2, single for COVID-19 immunisation. Medical history included crohn's disease, dairy intolerance and shellfish. The patient previously took first dose of (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution For Injection, Lot Number: EN6198) via an unspecified route of administration in left arm on 28Feb2021 11:00 (at the age of 26 years) as single for COID-19 immunisation and experienced fatigue nausea and arthralgia. On 22Mar2021 09:00, the patient experienced fatigue, nausea, joint pain, light headache, brain fog, trouble concentrating, high anxiety and loss of taste. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received medication within 2 weeks of vaccination. She was not pregnant at the time of vaccination. She did not receive treatment for Adverse event. Facility where the most recent COVID-19 vaccine was administered at hospital. The clinical outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Pt complaint severe dizziness for 3 days. Felt 1/2 as bad on the 4th day, and 1/4 as bad on the 5th day.
Severe lower abdominal pain 2 days after vaccine. Period like cramps, but worse with no period involved. 4 days after my first dose of the vaccine I began to have a tight pressure feeling in my chest, and it felt like there was a ball in it almost. The next day this continued to persist so I went to the ER and they diagnosed me with pericarditis.
brief loss of consciousness lasting about 10 seconds following administration of vax; ammonia inhalant put to nose to revive pt;
Patient complained of redness, purple color, swelling and red streaking from the injection site. Pt also saw a red bump where the vaccine was administered.  Patient received needle free vaccine this year, which was different from previous years.
Within 48 hrs of recving 2nd dose on 1982 pt devel redness & swelling @ the injection site, a fever of 103 F, malaise & weakness.Blood cultures were neg. Tx w/ ATBs & recovered. Recently titer found to be 1.1. No further details provided.
Migrane headache, dizziness, motion sickness, arm still hurts, body aches, fatigue, tiredness., chills.
Not appropriate dose.  Novavax only authorized for 1st booster dose.    No adverse symptoms.
he was ache all over; his arm hurts; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 24th June 2022, the patient received Shingles vaccine. On 24th June 2022, less than a day after receiving Shingles vaccine, the patient experienced pain in arm. On 25th June 2022, the patient experienced general body pain. On an unknown date, the outcome of the pain in arm was unknown and the outcome of the general body pain was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm and general body pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-Jun-2022 Reporters comment: The case was reported by patient's wife via interactive digital media. The patient received a dose of shingles vaccine and his arm hurt more than any other shot. Today (on the day of reporting), 1 day after receiving vaccination the patient was ache all over. The reporter wanted to know if anyone else had these symptoms after getting the shot. Follow up was not possible as no contact details were available.
Sick; Initial information regarding this unsolicited valid non-serious social media  case received from a consumer (patient) on 05-Dec-2020 .  This case involves a patient with unknown demographics who experienced sick (Illness) when received vaccine INFLUENZA VACCINE.  Relevant medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, (unknown latency) the patient experienced sick (Illness), following the administration of INFLUENZA VACCINE (flu shot). No flu shot for 25 years now.  Relevant laboratory test not reported.  It was not reported if the patient received a corrective medication.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on batch number for this case.
Pt developed a 6 inch reddened area on left arm with slight edema. Treated with Cephalexin.
Sore arm the evening of 10/14/2022. Began to feel unwell 10/15/22-Felt like I had a fever, aches, chills, mild cough. took at home COVID-19 Test and it was positive. Called doctor's office. Prescribed Paxlovid and Fluzone Hi-Dose Quad cough Syrup. 10/16/22-Felt unwell and had a fever of abiut 101 at the high point 10/17-unwell with fever 10/18-feeling better but without a fever, but have cough Wife Developed COVID-19 Symptons 0n 10/18.
Had completely forgotten about the nosebleeds I got after my Covid vaccine initial shots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 29Jan2021 at 11:15 as dose 1, single (Lot number: EL9261) intramuscular, in arm for covid-19 immunisation; diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP), on 14Jan2021 as dose number unknown, single (Batch/Lot number: unknown) intramuscular, in arm for immunisation. The patient's relevant medical history included: "ESRD", start date: 10Feb1996, stop date: 20Sep1998, notes: Pertinent Details: CAPD; "Renal TX", start date: 20Sep1998 (ongoing), notes: Renal TX , Pertinent details: still working; "HFPEF" (ongoing), notes: HFPEF, Pertinent details: aortic valve replacement 2011. The patient's concomitant medications were not reported.  The following information was reported: EPISTAXIS (non-serious), outcome "unknown", described as "Had completely forgotten about the nosebleeds I got after my Covid vaccine initial shots". Relevant laboratory tests and procedures are available in the appropriate section.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200098796 same patient, same drug, different dose/events(1st dose);
Knee pain when bending knee; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA. At the time of the report, ARTHRALGIA outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       No concomitant medication reported. No treatment information was provided.
tired; itchy rash on arm; Drug dose administration interval too short; Chills; Aches; feeling like they have a virus; sleepy; no energy; fever; sweating; queasy stomach; This case was reported by a physician via call center representative and described the occurrence of chills in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of chills (received 1st dose on 23rd April 2019 refer case US2019079110).   On 20th May 2019, the patient received the 2nd dose of Shingrix. In May 2019, several hours after receiving Shingrix, the patient experienced chills, pain, fever, sweating, queasy, viral infection, sleepiness and loss of energy. On 20th May 2019, the patient experienced drug dose administration interval too short. On 21st May 2019, the patient experienced itchy rash. On an unknown date, the patient experienced tiredness. The patient was treated with antihistamine (Antihistamines). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the chills, pain, tiredness, fever, sweating, queasy, itchy rash, viral infection, sleepiness and loss of energy were not recovered/not resolved and the outcome of the drug dose administration interval too short was unknown.   It was unknown if the reporter considered the chills, pain, tiredness, fever, sweating, queasy, itchy rash, viral infection, sleepiness and loss of energy to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in left arm. The physician reported that his patient had a prolonged reaction to Shingrix after receiving the second dose. A few hours after receiving the dose the patient develop a fever of 101 degree F, chills, sweating, aches and a queasy stomach.  One day after the vaccination, the patient reported developing an itchy rash on the Left arm but not near the injection site. The rash measured 3 by 2 inch and was not resolved with antihistamines.  The patient has continued to complain of chills, sweats feeling like they have a virus, they are tired, sleepy with no energy.  The physician monitoring the patient was ongoing. No additional details provided at the time of report.
had her 1st dose of Covid vaccine yesterday and started experiencing all expected side effects today including lost of smell and taste/ Rapid PCR Test which came back positive; had her 1st dose of Covid vaccine yesterday and started experiencing all expected side effects today including lost of smell and taste/ Rapid PCR Test which came back positive; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not provided), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had her 1st dose of COVID vaccine yesterday, 07Jan2021 and started experiencing all expected side effects today (08Jan2021) including loss of smell and taste. She also had a Rapid PCR test done today which came back positive. She wanted to know if this could be a false positive result from the vaccine. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.
Woke up in middle of night with swollen eyes /bumps on eyelids and itchy redness on chest
COVID arm; Extreme itching at the injection site; Rash at the injection site; Painful to touch and sensitive at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (Extreme itching at the injection site), VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE PAIN (Painful to touch and sensitive at the injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE REACTION (COVID arm), VACCINATION SITE PRURITUS (Extreme itching at the injection site), VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE PAIN (Painful to touch and sensitive at the injection site). On 05-Feb-2021, VACCINATION SITE PRURITUS (Extreme itching at the injection site) had resolved. On 08-Feb-2021, VACCINATION SITE REACTION (COVID arm), VACCINATION SITE RASH (Rash at the injection site) and VACCINATION SITE PAIN (Painful to touch and sensitive at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication and treatment drug were not reported.    Most recent FOLLOW-UP information incorporated above includes: On 20-Feb-2021: Email added On 28-Apr-2021: Follow up received on 28apr2021 contains no new information. On 28-Jun-2021: Report content no new information.
After the vaccines lost temperature they were administered; A spontaneous report was received from a healthcare professional concerning a 68-year-old, White, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event, after the vaccines lost temperature they were administered.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Jan 2021, a refrigerator in a vaccine clinic lost power and rose up to room temperature overnight. At approximately 9 p.m., the vaccines inside the refrigerator reached room temperature.  On 12 Jan 2021, after the vaccine lost temperature, the patient received their first of two planned doses of mRNA-1273 (Lot number: 027L20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  No treatment information was provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The event, after the vaccines lost temperature they were administered, was considered resolved on 12 Jan 2021.; Reporter's Comments: This case concerns a 68-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot: 027L20A), reporting Out of specification product use.